Jung‐Yi Lin
Impact in
-
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Glioma Diagnosis and Treatment
Papers in
-
- Pharmacological Effects and Toxicity Studies 6
-
- Epilepsy research and treatment 5
- Co-authors
- Umut Özbek (4 shared papers)Myron Schwartz (1 shared paper)Max W. Sung (1 shared paper)Celina Ang (2 shared papers)Sirish Dharmapuri (1 shared paper)Andrea D. Branch (1 shared paper)Rut Tejero (1 shared paper)Madhu Mazumdar (7 shared papers)
- Journals
- Epilepsia (3 papers)Epilepsy & Behavior (2 papers)BMC Health Services Research (1 paper)Oral Oncology (1 paper)Health Services Research (1 paper)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Jung‐Yi Lin
14 papers receiving 259 citations
Peers
Comparison fields: 5 of 69
- Hepatology 46
- Genetics 57
- Oncology 125
- Cancer Research 57
- Health Informatics 3
Countries citing papers authored by Jung‐Yi Lin
This map shows the geographic impact of Jung‐Yi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung‐Yi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung‐Yi Lin more than expected).
Fields of papers citing papers by Jung‐Yi Lin
This network shows the impact of papers produced by Jung‐Yi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung‐Yi Lin. The network helps show where Jung‐Yi Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Jung‐Yi Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 88 | |
| 2 | 2020 | 82 | |
| 3 | 2020 | 34 | |
| 4 | 2019 | 15 | |
| 5 | 2020 | 10 | |
| 6 | 2022 | 7 | |
| 7 | 2020 | 5 | |
| 8 | 2020 | 5 | |
| 9 | 2021 | 4 | |
| 10 | 2021 | 3 | |
| 11 | 2021 | 3 | |
| 12 | 2021 | 3 | |
| 13 | 2020 | 2 | |
| 14 | 2021 | 2 | |
| 15 | 2025 | 0 |
About Jung‐Yi Lin
Jung‐Yi Lin is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health, Pulmonary and Respiratory Medicine, Oncology and Genetics, having authored 15 papers that have together received 263 indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (6 papers), Epilepsy research and treatment (5 papers), Intensive Care Unit Cognitive Disorders (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Glioma Diagnosis and Treatment (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Mesenchymal stem cell research (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Hepatology (46 citations), Genetics (57 citations), Oncology (125 citations), Cancer Research (57 citations) and Health Informatics (3 citations). Jung‐Yi Lin has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Umut Özbek, Myron Schwartz, Max W. Sung, Celina Ang, Sirish Dharmapuri, Andrea D. Branch, Rut Tejero, Madhu Mazumdar, Caroline C. Friedel and Hongyan Zou. Their work appears in journals such as Epilepsia, Epilepsy & Behavior, BMC Health Services Research, Oral Oncology and Health Services Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.